Macroalgae – or seaweed – farming has taken off in recent years, spurring innovation. With 12,000 species spread around the world’s oceans, there’s a lot of untapped biomass ripe for harvesting. Katrina Megget reports
The success of the cutting-edge CAR-T cancer treatment that involves transforming a patient’s immune cells so they can identify and destroy cancer cells has led to a broad range of developments and improvements. Future modifications promise hope for a wider range of cancers and other diseases.
The legal conflicts over the intellectual property around Crispr-Cas9 gene editing show no sign of ending. But what does that mean for companies seeking to use this technology? Anthony King reports
SCI’s CEO Sharon Todd talks to Liam Condon, the CEO of Johnson Matthey about the path the company has taken, and where it goes next.
CPChem’s Chief Executive Steve Prusak spoke to C&I's Steve Ranger about how the company has grown over the last 25 years, its priorities and how it approaches innovation.